LECTURES
& BREAKOUTS
Wednesday,
June 14, 2000 |
|
Time
|
Title |
Speaker |
|
 |
| 8:00-8:30
|
Welcome
and Charge for the Meeting |
Scott Saxman,
MD
Richard L. Cumberlin, MD |
  |
|
| 8:30-9:15
|
Current
Therapy and Future Directions in the Multimodality Treatment of Locally
Advanced Non-Small Cell Lung Cancer |
David
R. Gandara, MD |
|
|
|
9:15-10:00 |
Molecular
Abnormalities in Lung Cancer and the Potential for Novel Therapeutics
|
Ravi
Salgia, MD, PhD |
|
|
|
10:00-10:30 |
Mechanisms
of Chemosresistance in Non-Small Cell Lung Cancer: How Might We
Overcome Them?
|
Jessie
L. S. Au, PharmD, PhD |
|
|
|
10:45-11:15 |
Mechanisms
of Resistance to Radiotherapy in Non-Small Cell Lung Cancer—How Might
We Overcome Them? |
W.
Gillies McKenna, MD, PhD |
|
| |
| 11:15-11:45 |
Integrating
Radiotherapy with New Therapeutic Agents for the Treatment of Locally
Advanced Non-Small Cell Lung Cancer. What Do We Know? What Do We Need
to Know? |
C.
Norman Coleman, MD |
|
| |
| 11:15-11:45 |
Discussion |
|
|
| |
| |
|
Thursday,
June 15, 2000
|
|
Time
|
Title |
Speaker |
|
| |
|
8:00-8:45 |
Advances
in Imaging for Non-Small Cell Lung Cancer. What’s New? How Could These
Technologies Be Applied to Clinical Trials? |
Edward
F. Patz, Jr., MD |
|
|
|
9:15-10:00 |
Breakout
Session A:
Antiangiogenesis Agents: Therapeutic Directions |
Paul
A. Bunn, Jr., MD
Walter J. Curran, Jr., MD |
|
| |
| 8:45-9:15
|
Discussion |
|
|
| |
| 10:15-10:45 |
Breakout
Session B:
Immunotherapy/Biologics/Gene Therapy: Therapeutic Directions |
David
R. Parkinson, MD
Jack A. Roth, MD |
|
| |
| 10:45-11:30 |
Discussion |
|
|
| |
| 11:30-12:00
|
Breakout
Session C:
Agents that Target Cellular Pathways and New Chemotherapeutic Agents:
Therapeutic Directions |
Frances
A. Shepherd, MD, FRCP
Rupert K. Schmidt-Ulrich, MD |
|
| |
| 12:00-12:45
|
Discussion |
|
|
